Mental Health Burden in People Living With HIV: Depression, Anxiety and Stress

Why Are Depression and Anxiety So Common in People Living With HIV?

People living with HIV (PLHIV) experience mental health conditions at rates considerably higher than the general population. A recent cross-sectional study conducted at antiretroviral therapy (ART) centres in Western Rajasthan, India, published in Cureus, adds to a growing evidence base showing that depression, anxiety and stress are widespread among PLHIV, even among those stable on long-term treatment. The researchers assessed psychological distress using validated scales and found a substantial proportion of participants met thresholds for clinically relevant symptoms.

The drivers are multifactorial. Chronic inflammation associated with HIV infection can influence neurotransmitter systems implicated in mood disorders. Antiretroviral regimens, while life-saving, have historically included agents such as efavirenz that were linked to neuropsychiatric effects. Beyond biology, stigma, discrimination, disclosure fears, financial strain and loss of social support remain powerful determinants of mental health outcomes, particularly in lower- and middle-income settings.

How Does Poor Mental Health Affect HIV Treatment Outcomes?

The World Health Organization and UNAIDS have repeatedly emphasised that mental health is inseparable from HIV outcomes. Depression is consistently associated with lower adherence to antiretroviral therapy, missed clinic visits and poorer viral suppression. These downstream effects not only worsen individual prognosis but also undermine public health goals around ending HIV as a global epidemic by 2030.

Integrated care models, in which mental health screening and brief interventions are embedded within ART clinics, have shown promise. The WHO mhGAP programme and collaborative care trials in sub-Saharan Africa and South Asia suggest that task-shifting to trained non-specialist providers can meaningfully reduce depressive symptoms while supporting retention in HIV care. The Rajasthan study reinforces the argument that every ART centre should include routine, validated psychological assessment.

What Can Be Done to Close the Mental Health Gap in HIV Care?

Closing the mental health gap starts with systematic screening. Tools such as the PHQ-9 for depression, GAD-7 for anxiety and DASS-21 for combined symptom assessment are brief, validated and feasible in busy ART clinics. When screening identifies concerns, clear referral pathways to counselling, group-based cognitive behavioural therapy, or pharmacotherapy where appropriate are essential.

Community-level interventions matter equally. Peer support groups, anti-stigma campaigns and socioeconomic support programmes address the upstream causes of distress. For clinicians, awareness of drug interactions between antidepressants and antiretrovirals, particularly via cytochrome P450 pathways, is important when initiating pharmacological treatment. Global guidance from WHO continues to recommend integrated, person-centred HIV care that addresses mental, sexual and physical health together.